Bactiguard's coating reduces thrombo-inflammatory reactions and acute stent thrombosis - new study published

Contributed by: PR Newswire

Tags

Bactiguard-Holding

More Like This

BD to become exclusive global license partner (excluding China) for Bactiguard coated Foley catheters

The Bare Temporary Spur Stent System is a unique clinical solution known as Retrievable Stent Therapy, or RST. It is intended to provide stent-like results while leaving no metal behind. (Graphic: Business Wire)

Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions

PR Newswire associated0

Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study

PR Newswire associated0

Plasmalex launches PlasmaGuard® X: The new generation of 100% PFAS-free conformal barrier coatings

PR Newswire associated0

VST BIO Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Monoclonal Antibody to Treat Ischemic Stroke at AHA International Stroke Conference

Rapid Medical™ Announces Japanese Approval and Exclusive Partnership With Kaneka for TIGERTRIEVER–The World’s Only Adjustable Thrombectomy Device

The first and only retrievable stent system that features a self-expanding stent with an integrated dilatation balloon catheter on an over-the-wire system. It is designed for controlled lesion penetration and treatment through a series of radially expandable spikes. Known as Retrievable Scaffold Therapy (RST), the spikes on the Spur Stent penetrate the lesion to increase the acute luminal diameter and modify the lesion morphology to change vessel compliance and reduce vessel recoil effect.

FDA Grants De Novo Clearance for Reflow Medical's Spur® Peripheral Retrievable Stent System

PR Newswire associated0

FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY